Molecular Partners AG (SWX:MOLN)
Switzerland · Delayed Price · Currency is CHF 3.490
0.00 (0.00%)
Aug 21, 2026, 5:31 PM CET
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of 130.91 million as of August 21, 2026. Its market cap has increased by 21.79% in one year.
Market Cap
130.91M
Enterprise Value
55.49M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.49
ChartMarket Cap Chart
Since November 4, 2014, Molecular Partners AG's market cap has decreased from 426.07M to 130.91M, a decrease of -69.27%. That is a compound annual growth rate of -9.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 130.91M | 3.41% |
| Dec 30, 2025 | 126.60M | -15.41% |
| Dec 30, 2024 | 149.66M | 32.42% |
| Dec 29, 2023 | 113.02M | -43.62% |
| Dec 30, 2022 | 200.48M | -65.16% |
| Dec 30, 2021 | 575.43M | -4.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.74B |
| Idorsia | 1.52B |
| Basilea Pharmaceutica AG | 775.19M |
| Newron Pharmaceuticals | 269.64M |
| Santhera Pharmaceuticals Holding AG | 258.63M |
| BioVersys AG | 147.22M |
| Xlife Sciences AG | 87.53M |
| MindMaze Therapeutics Holding | 31.82M |